Effects of antiplatelet drugs on dialysis-associated platelet deposition in polytetrafluoroethylene grafts

American Journal of Kidney Diseases

Volumn 29, Issue 4, 1997, Pages 560-564

  Windus, David W ^a   Santoro, Samuel A ^b   Atkinson, Ralph ^b   Royal, Henry D ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b NONE

Author keywords

aspirin; platelet aggregation; Platelets; polytetrafluoroethylene; ticlopidine

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; SULFINPYRAZONE; THROMBOCYTE IN 111; TICLOPIDINE;

ARTERIOVENOUS SHUNT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; THROMBOCYTE ADHESION; THROMBOCYTE ADHESIVENESS; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0030975758     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90338-3     Document Type: Article

References (16)

1. Ritchie JL, Lindner A, Hamilton GW, Harker LA: Inoxine platelet imaging in hemodialysis patients: Detection of platelet deposition at vascular access sites. Nephron 31:333-336, 1982
2. Windus DW, Santoro S, Royal HD: The effects of hemodialysis on platelet deposition in prosthetic graft fistulas. Am J Kidney Dis 26:614-621, 1995
3. Diskin CJ, Stokes TJ Jr, Pennell AT: Pharmacologic intervention to prevent hemodialysis vascular access thrombosis. Nephron 64:1-26, 1993
4. Oblath RW, Buckley FOJ, Green RM, Schwartz SI, DeWeese JA: Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 84:37-44, 1978
5. Harter HR, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, Weerts CA: Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301:577-579, 1979
6. Kobayashi K, Maeda K, Koshikawa S, Kwaguchi Y, Shimuzu N, Naito C: Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis: A multicenter collaborative double blind study. Thromb Res 20:255-261, 1980
7. Fiskerstrand CE, Thompson IW, Burnet ME, Williams P, Anderton JL: Double-blind randomized trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. Artif Organs 9:61-63, 1985
8. Grontoft K, Mulec H, Gutierrez A, Olander R: Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for hemodialysis. Scand J Urol Nephrol 19:55-57, 1985
9. Domoto DT, Baumann JE, Joist JH: Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 62:737-743, 1991
10. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM: Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study. Kidney Int 45:1477-1483, 1994
11. Chu LL, MacGregor RR, Hamilton JW, Cohn DV: Conversion of proparathyroid hormone to parathyroid hormone: The use of amines as specific inhibitors. Endocrinology 95:1431-1438, 1974
12. Santoro SA, Cunningham LW: Collagen mediated platelet aggregation - Evidence for multivalent interactions of intermediate specificity between collagen and platelets. J Clin Invest 60:1054-1060, 1977
13. O'Brien JR: Effects of salicylates on human platelets. Lancet 1:779-783, 1968
14. Livio M, Benigni A, Vigano G, Mecca G, Remuzzi G: Moderate doses of aspirin and the risk of bleeding in renal failure. Lancet 1:414-416, 1986
15. Thebault JJ, Blatrix CE, Blanchard JF, Panal EA: Effects of ticlopidine, a new platelet aggregation inhibitor in man. Clin Pharmacol Ther 18:485-490, 1975
16. Hardisty RM, Powling MJ, Nokes TJC: The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins. Thromb Haemost 64:150-155, 1990